BioWorld MedTech

May 25, 2010

Regulatory path uncertainty a big-time concern for VCs

MINNEAPOLIS – If you want to know about the state of healthcare investing, who better to ask than those who pull the trigger, or maybe don't? (Medical Device Daily) Read More

PVI helps assess hypotension risk during anesthesia

Washington roundup: IRS publishes guidelines for healthcare reform tax credit

Medispec develops 'shocking' solution for vessel growth

Report from Europe: SyntheMed's adhesion barrier film gets CE mark approval

Coming Wednesday in MDD Perspectives: Technology isn't silverbullet,without human change

Deals roundup: ZyGEM acquires Microlab, plans to integrate products

Court report: Hospital settles pay-to-play qui tam suit for $108 million

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 14, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 14, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...